Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Stiasny-Kolster

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Neuropsychobiology|June 5, 2004
Low-dose pramipexole in the management of restless legs syndrome. An open label trialKarin Stiasny-Kolster, Wolfgang H Oertel
Sleep Medicine|December 22, 2009
Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care populationCaroline Möller, Thomas C Wetter, Jürgen Köster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2007
Update of the pathophysiology of the restless-legs-syndromeWalter Paulus, Pascal Dowling, Roselyne Rijsman, et al.
Journal of the Neurological Sciences|September 17, 2009
Restless Legs Syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities?Jens Carsten Möller, Marcus Unger, Karin Stiasny-Kolster, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Health-related quality of life and economic burden in patients with restless legs syndromeJens P Reese, Karin Stiasny-Kolster, Wolfgang H Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 18, 2006
Validation of the "L-DOPA test" for diagnosis of restless legs syndromeKarin Stiasny-Kolster, Ralf Kohnen, Jens Carsten Möller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot studyKarin Stiasny-Kolster, Ralf Kohnen, Erwin Schollmayer, et al.
Pain|May 28, 2013
Hyperalgesia and functional sensory loss in restless legs syndromeKarin Stiasny-Kolster, Doreen B Pfau, Wolfgang H Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 23, 2007
Pathophysiological concepts of restless legs syndromeWalter Paulus, Pascal Dowling, Roselyne Rijsman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 7, 2006
Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndromeClaudia Trenkwalder, Karin Stiasny-Kolster, Andreas Kupsch, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Neuropsychobiology|June 5, 2004
Low-dose pramipexole in the management of restless legs syndrome. An open label trialKarin Stiasny-Kolster, Wolfgang H Oertel
Sleep Medicine|December 22, 2009
Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care populationCaroline Möller, Thomas C Wetter, Jürgen Köster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2007
Update of the pathophysiology of the restless-legs-syndromeWalter Paulus, Pascal Dowling, Roselyne Rijsman, et al.
Journal of the Neurological Sciences|September 17, 2009
Restless Legs Syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities?Jens Carsten Möller, Marcus Unger, Karin Stiasny-Kolster, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Health-related quality of life and economic burden in patients with restless legs syndromeJens P Reese, Karin Stiasny-Kolster, Wolfgang H Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 18, 2006
Validation of the "L-DOPA test" for diagnosis of restless legs syndromeKarin Stiasny-Kolster, Ralf Kohnen, Jens Carsten Möller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot studyKarin Stiasny-Kolster, Ralf Kohnen, Erwin Schollmayer, et al.
Pain|May 28, 2013
Hyperalgesia and functional sensory loss in restless legs syndromeKarin Stiasny-Kolster, Doreen B Pfau, Wolfgang H Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 23, 2007
Pathophysiological concepts of restless legs syndromeWalter Paulus, Pascal Dowling, Roselyne Rijsman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 7, 2006
Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndromeClaudia Trenkwalder, Karin Stiasny-Kolster, Andreas Kupsch, et al.
Pageof 6